Home > Boards > US Listed > Biotechs > Contrafect Corp (CFRX)

Anyone able to verify as to why this

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
420man Member Profile
Member Level 
Followed By 57
Posts 4,509
Boards Moderated 1
Alias Born 11/20/13
160x600 placeholder
X-Biotix Therapeutics Joins Antimicrobials Working Group PR Newswire (US) - 7/1/2019 9:13:00 AM
Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2019 PR Newswire (US) - 6/20/2019 11:13:00 AM
ContraFect Announces ASM Microbe 2019 Outstanding Abstract Award and Presentation of New Data GlobeNewswire Inc. - 6/17/2019 5:00:00 PM
Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Inno... PR Newswire (US) - 6/7/2019 9:27:00 AM
ContraFect Awarded $7.2 Million USAMRDC Grant to Support the Advancement of Lysin Candidate CF-296 GlobeNewswire Inc. - 6/6/2019 7:00:00 AM
ContraFect Announces Presentation at the International Society of Cardiovascular Infectious Diseases Symposium GlobeNewswire Inc. - 6/3/2019 7:00:00 AM
ContraFect Announces Publication of Paper on Recent Exebacase Data in Antimicrobial Agents and Chemotherapy Journal GlobeNewswire Inc. - 5/31/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/29/2019 5:02:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2019 4:35:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2019 4:33:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2019 4:27:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2019 4:25:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2019 4:22:57 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/13/2019 5:30:16 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 4:24:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/10/2019 4:13:39 PM
ContraFect Reports First Quarter 2019 Financial Results and Provides Business Update GlobeNewswire Inc. - 5/10/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/9/2019 4:53:42 PM
ContraFect to Host R&D Symposium on Direct Lytic Agents (Lysins and Amurins) with Clinical Thought Leaders on Infectious Dise... GlobeNewswire Inc. - 5/8/2019 7:00:00 AM
ContraFect Presents Additional Positive Data from the Phase 2 Trial of Exebacase at the 29th European Congress of Clinical Mi... GlobeNewswire Inc. - 4/16/2019 5:15:00 AM
Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology a... PR Newswire (US) - 4/12/2019 10:08:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 4/10/2019 1:30:46 PM
ContraFect Announces Publication of Exebacase Data in Antimicrobial Agents and Chemotherapy Journal GlobeNewswire Inc. - 4/8/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/4/2019 1:30:22 PM
ContraFect Announces Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) GlobeNewswire Inc. - 4/4/2019 7:00:00 AM
420man Member Level  Monday, 01/07/19 04:40:38 PM
Re: None
Post # of 117 
Anyone able to verify as to why this dropped so hard today when the PR indicated positive endpoint results? TIA

Penny Land is a wack-a-mole game
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist